Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease

Breast Journal

Volumn 8, Issue 1, 2002, Pages 2-9

  Rivera, Edgardo ^a,b   Holmes, Frankie A ^a   Buzdar, Aman U ^a   Asmar, Lina ^a   Kau, Shu Wan ^a   Fraschini, Giuseppe ^a   Walters, Ronald ^a   Theriault, Richard L ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast; Chemotherapy; Isolated; Malignancy; Recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; PROGNOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PROSPECTIVE STUDIES; TAMOXIFEN; TREATMENT OUTCOME;

EID: 0036166168     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2002.08002.x     Document Type: Article

References (21)

1. Combined modality approach in breast cancer with isolated multiple metastases
2. A biostatistical study of locally recurrent breast carcinoma
3. Patterns of relapse and survival following radical mastectomy: Analysis of 716 consecutive patients
4. Prognosis and treatment of loco-regional breast cancer recurrences: Critical consideration on 120 cases
5. The implications of local recurrence of breast cancer as the first site of therapeutic failure
6. The significance of local recurrence of carcinoma of the breast
7. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer
8. The significance of supraclavicular fossa node recurrence after mastectomy
9. Local or regionally recurrent carcinoma of the breast: Results of therapy in 121 patients
10. Adjuvant chemotherapy following regional therapy for isolated recurrences of breast cancer (stage IV-NED)
11. Combined modality approach for patients with isolated recurrences of breast cancer (IV-NED): The M. D. Anderson Cancer Center experience
12. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation
13. Extended survival in 80 patients with operable breast cancer (stage IV NED) treated with chemotherapy
14. Non-parametric estimation from incomplete observations
15. Evaluation of survival data and two new rank order statistics rising in its consideration
16. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
17. The effect of adjuvant radiotherapy on the time of occurrence and prognosis of local recurrence in primary operable breast cancer
18. Results of irradiation in the treatment of locoregional breast cancer recurrence
19. Management of locoregional recurrent breast cancer
20. Tamoxifen for early breast cancer: An overview of the randomized trials